Status:
UNKNOWN
Safety and Efficacy of Low-intensity Laser Therapy in the Treatment of Chronic Musculoskeletal Pain
Lead Sponsor:
Tongji Hospital
Collaborating Sponsors:
Shanxi Bethune Hospital
Second Hospital of Shanxi Medical University
Conditions:
Pain, Chronic
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is a multicenter, prospective, randomized, controlled research design. This study takes classic NSAIDs treatment as a control, and it will take patients' pain relief, functional improvement...
Detailed Description
Research purpose: Chronic musculoskeletal pain is the most common clinical Chronic pain. Non-steroidal drugs are the most commonly used therapeutic drugs, but their effects on improving the body func...
Eligibility Criteria
Inclusion
- Age ≥ 18 years old;
- Chronic musculoskeletal pain (including cervical spondylosis, periarthritis of shoulder, osteoarthritis, back muscle Fasciitis, lumbar disc herniation) was diagnosed, and the pain lasted for more than 3 months;
- The degree of pain before treatment was mild to moderate (NRS score\<7 points);
- Can cooperate in completing consultation and scale evaluation;
- Sign an informed consent form.
Exclusion
- Previous spinal surgery or severe spinal diseases (such as fractures, tumors, inflammation, and infectious diseases);
- Suffering from serious systemic diseases, including liver and kidney dysfunction, cardio cerebral, vascular disease, decompensated metabolic syndrome;
- Serious skin diseases (skin cancer, erysipelas, severe eczema, severe dermatitis, severe psoriasis, lupus, Hives);
- Suffering from mental disorders, intellectual disabilities, epilepsy and other diseases;
- Moderate to severe depressive state;
- Have a history of drug abuse, drug abuse, and alcohol abuse;
- Individuals with contraindications to NSAIDs or laser therapy;
- Pregnant women;
- Recently participated in other clinical studies.
Key Trial Info
Start Date :
September 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 21 2024
Estimated Enrollment :
860 Patients enrolled
Trial Details
Trial ID
NCT06009900
Start Date
September 1 2023
End Date
December 21 2024
Last Update
August 24 2023
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
China Resources & WISCO General Hospital
Wuhan, Hubei, China
2
LinFen People's Hospital
Linfen, Shanxi, China
3
Second Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
4
Shanxi Bethune Hospital
Taiyuan, Shanxi, China